ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 55 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$282,000
+2.2%
48,644
-24.6%
0.00%0.0%
Q2 2018$276,000
-62.1%
64,544
-48.0%
0.00%
-50.0%
Q1 2018$728,000
+11.1%
124,064
-12.4%
0.00%0.0%
Q4 2017$655,000
+12.5%
141,700
+33.7%
0.00%0.0%
Q3 2017$582,000
+43.0%
106,000
+50.0%
0.00%
+100.0%
Q2 2017$407,00070,6440.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders